These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 29970562)

  • 1. Inhibition of Survivin by Adenovirus Vector Enhanced Paclitaxel-induced Apoptosis in Breast Cancer Cells.
    Tanaka T; Uchida H
    Anticancer Res; 2018 Jul; 38(7):4281-4288. PubMed ID: 29970562
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination of survivin siRNA with neoadjuvant chemotherapy enhances apoptosis and reverses drug resistance in breast cancer MCF-7 cells.
    Dong H; Yao L; Bi W; Wang F; Song W; Lv Y
    J Cancer Res Ther; 2015; 11(4):717-22. PubMed ID: 26881507
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adenovirus-mediated inhibition of survivin expression sensitizes human prostate cancer cells to paclitaxel in vitro and in vivo.
    Zhang M; Mukherjee N; Bermudez RS; Latham DE; Delaney MA; Zietman AL; Shipley WU; Chakravarti A
    Prostate; 2005 Aug; 64(3):293-302. PubMed ID: 15754318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of survivin by retinoic acid and its role in paclitaxel-mediated cytotoxicity in MCF-7 breast cancer cells.
    Pratt MA; Niu MY; Renart LI
    Apoptosis; 2006 Apr; 11(4):589-605. PubMed ID: 16528475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adenovirus-mediated transfer of siRNA against survivin induced apoptosis and attenuated tumor cell growth in vitro and in vivo.
    Uchida H; Tanaka T; Sasaki K; Kato K; Dehari H; Ito Y; Kobune M; Miyagishi M; Taira K; Tahara H; Hamada H
    Mol Ther; 2004 Jul; 10(1):162-71. PubMed ID: 15233951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prodigiosin down-regulates survivin to facilitate paclitaxel sensitization in human breast carcinoma cell lines.
    Ho TF; Peng YT; Chuang SM; Lin SC; Feng BL; Lu CH; Yu WJ; Chang JS; Chang CC
    Toxicol Appl Pharmacol; 2009 Mar; 235(2):253-60. PubMed ID: 19133282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [siRNA against survivin coupling with epirubicin enhances to induce breast cancer cell MCF-7 to apoptosis].
    Guan HT; Xue XH; Wang XJ; Li A; Qin ZY
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2006 Mar; 37(2):221-5. PubMed ID: 16608080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes of survivin mRNA and protein expression during paclitaxel treatment in breast cancer cells.
    Xiong H; Yu S; Zhuang L; Xiong H
    J Huazhong Univ Sci Technolog Med Sci; 2007 Feb; 27(1):65-7. PubMed ID: 17393113
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor-specific adenovirus-mediated PUMA gene transfer using the survivin promoter enhances radiosensitivity of breast cancer cells in vitro and in vivo.
    Wang R; Wang X; Li B; Lin F; Dong K; Gao P; Zhang HZ
    Breast Cancer Res Treat; 2009 Sep; 117(1):45-54. PubMed ID: 18791823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BRCA1 modulates malignant cell behavior, the expression of survivin and chemosensitivity in human breast cancer cells.
    Promkan M; Liu G; Patmasiriwat P; Chakrabarty S
    Int J Cancer; 2009 Dec; 125(12):2820-8. PubMed ID: 19551867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Survivin siRNA increases sensitivity of primary cultures of ovarian cancer cells to paclitaxel.
    Kar R; Palanichamy JK; Banerjee A; Chattopadhyay P; Jain SK; Singh N
    Clin Transl Oncol; 2015 Sep; 17(9):737-42. PubMed ID: 26033427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated expression of erbB3 confers paclitaxel resistance in erbB2-overexpressing breast cancer cells via upregulation of Survivin.
    Wang S; Huang X; Lee CK; Liu B
    Oncogene; 2010 Jul; 29(29):4225-36. PubMed ID: 20498641
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survivin family proteins as novel molecular determinants of doxorubicin resistance in organotypic human breast tumors.
    Faversani A; Vaira V; Moro GP; Tosi D; Lopergolo A; Schultz DC; Rivadeneira D; Altieri DC; Bosari S
    Breast Cancer Res; 2014 May; 16(3):R55. PubMed ID: 24886669
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-218 targets survivin and regulates resistance to chemotherapeutics in breast cancer.
    Hu Y; Xu K; Yagüe E
    Breast Cancer Res Treat; 2015 Jun; 151(2):269-80. PubMed ID: 25900794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential effect of anti-apoptotic genes Bcl-xL and c-FLIP on sensitivity of MCF-7 breast cancer cells to paclitaxel and docetaxel.
    Wang Z; Goulet R; Stanton KJ; Sadaria M; Nakshatri H
    Anticancer Res; 2005; 25(3c):2367-79. PubMed ID: 16080463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Paclitaxel tumor priming promotes delivery and transfection of intravenous lipid-siRNA in pancreatic tumors.
    Wang J; Lu Z; Wang J; Cui M; Yeung BZ; Cole DJ; Wientjes MG; Au JL
    J Control Release; 2015 Oct; 216():103-10. PubMed ID: 26272765
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Crocin enhances the sensitivity to paclitaxel in human breast cancer cells by reducing BIRC5 expression.
    Jia Y; Yang H; Yu J; Li Z; Jia G; Ding B
    Chem Biol Drug Des; 2024 Feb; 103(2):e14467. PubMed ID: 38661582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer gene therapy using a survivin mutant adenovirus.
    Mesri M; Wall NR; Li J; Kim RW; Altieri DC
    J Clin Invest; 2001 Oct; 108(7):981-90. PubMed ID: 11581299
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological and small interference RNA-mediated inhibition of breast cancer-associated fatty acid synthase (oncogenic antigen-519) synergistically enhances Taxol (paclitaxel)-induced cytotoxicity.
    Menendez JA; Vellon L; Colomer R; Lupu R
    Int J Cancer; 2005 May; 115(1):19-35. PubMed ID: 15657900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An oncolytic herpes simplex virus vector, G47Δ, synergizes with paclitaxel in the treatment of breast cancer.
    Zeng WG; Li JJ; Hu P; Lei L; Wang JN; Liu RB
    Oncol Rep; 2013 Jun; 29(6):2355-61. PubMed ID: 23525624
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.